| Literature DB >> 27303446 |
Mei Qu1, Bing Lv1, Xin Zhang1, Hanqiu Yan1, Ying Huang1, Haikun Qian1, Bo Pang2, Lei Jia1, Biao Kan2, Quanyi Wang1.
Abstract
BACKGROUND: Diarrhea is one of the main causes of morbidity and mortality among children less than 5 years of age worldwide, and its causes vary by region. This study aimed to determine the etiologic spectrum, prevalent characteristics and antimicrobial resistance patterns of common enteropathogenic bacteria from diarrheagenic children in Beijing, the capital of China.Entities:
Keywords: Antimicrobial resistance; Children; Diarrhea surveillance; Diarrheagenic bacteria
Year: 2016 PMID: 27303446 PMCID: PMC4906916 DOI: 10.1186/s13099-016-0116-2
Source DB: PubMed Journal: Gut Pathog ISSN: 1757-4749 Impact factor: 4.181
Demographic and illness characteristics of bacterial pathogens associated with childhood diarrhea in Beijing
| Characteristic | All enrolled subjects (n = 2524) |
|
|
|
| Total of all pathogens (n = 269) |
|---|---|---|---|---|---|---|
| Age (years), n (%) | ||||||
| <1 | 1497 (59.3) | 53 (3.5) | 44 (2.9) | 5 (0.3) | 6 (0.4) | 107 (7.1) |
| 1–2 | 844 (33.4) | 58 (6.9) | 52 (6.2) | 16 (1.9) | 4 (0.5) | 127 15.0) |
| 3–4 | 131 (5.2) | 5 (3.8) | 11 (8.4) | 9 (6.9) | 0 (0.0) | 25 (19.1) |
| =5 | 52 (2.1) | 1 (1.9) | 2 (3.8) | 7 (13.5) | 0 (0.0) | 10 (19.2) |
| Mean age ± SD | 1.2 (1.1) | 1.3 (1.0) | 1.5 (1.1) | 2.9 (1.8) | 1.1 (0.7) | 1.6 (1.3) |
| | – | 0.002 | <0.001 | <0.001 | 0.836 | <0.001 |
| Sex, n (%) | ||||||
| Male | 1616 (64.0) | 70 (4.3) | 71 (4.4) | 26 (1.6) | 3 (0.2) | 170 (10.5) |
| Female | 908 (36.0) | 47 (5.2) | 38 (4.2) | 11 (1.2) | 7 (0.8) | 99 (10.9) |
| | – | 0.333 | 0.517 | 0.302 | 0.025 | 0.765 |
| Seasons, n (%) | ||||||
| Spring (Mar–May) | 584 (23.1) | 22 (3.8) | 28 (4.8) | 0 (0.0) | 1 (0.1) | 50 (8.6) |
| Summer (Jun–Aug) | 1029 (40.8) | 62 (6.0) | 50 (4.9) | 31 (3.0) | 6 (0.6) | 146 (14.2) |
| Autumn (Sep–Nov) | 615 (24.4) | 27 (4.4) | 25 (4.1) | 6 (0.9) | 3 (0.5) | 61 (9.9) |
| Winter (Dec–Feb) | 296 (11.7) | 6 (5.1) | 6 (5.1) | 0 (0.0) | 0 (0.0) | 12 (2.0) |
| | – | 0.017 | 0.229 | <0.001 | 0.397 | <0.001 |
| Symptom, n (%) | ||||||
| Fever (>38 °C) | 181 (7.2) | 3 (2.6)b | 21 (19.3)b | 14 (37.8)b | 0 (0.0) | 38 (14.1)b |
| Abdominal pain | 112 (4.4) | 4 (3.4) | 8 (7.3) | 7 (18.9)b | 0 (0.0) | 19 (7.1)b |
| Vomiting | 165 (6.5) | 6 (5.1) | 5 (4.6) | 9 (24.3)b | 0 (0.0) | 20 (7.4) |
| Dehydration | 11 (0.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
| Watery diarrhea | 758 (30.0) | 38 (32.5) | 20 (18.3)b | 8 (21.6) | 1 (10.0) | 66 (24.5)b |
| Mucus diarrhea | 1724 (68.3) | 76 (65.0) | 87 (79.8)b | 26 (70.3) | 8 (80.0) | 193 (71.7) |
| Bloody diarrhea | 63 (2.5) | 2 (1.7) | 7 (6.4)b | 3 (8.1)b | 1(10.0) | 13 (4.8)b |
| Meandiarrhea frequency ± SD | 4.9 (2.4) | 4.3 (2.3) | 5.7 (2.6) | 6.9 (3.6) | 4.1 (1.6) | 5.2 (2.8) |
| Antibiotic consumption | 507 (20.1) | 25 (21.4) | 28 (25.7) | 23 (62.2) | 5 (50.0) | 79 (29.4) |
aOne specimen was identified by mixed infection of EPEC and EAEC, therefore n = 117; SD standard deviation
bChi square test was calculated by each symptomdue to different pathogen, all significant P values below 0.05 was noted
Distribution of different enteropathogenic bacteria(n = 274) isolated from diarrheal patients
| Any simple pathogen | No. of isolates (%) |
|---|---|
| Diarrheagenic | 118 (43.1) |
| EPEC | |
| Atypical (eae+ , | 58 (49.2) |
| Typical (eae+ , | 9 (7.6) |
| EAEC | |
| | 28 (23.7) |
| ETEC | |
| | 9 (7.6) |
| | 6 (5.1) |
| Both+ | 2 (1.7) |
| EIEC ( | 5(4.2) |
| STEC (eae + , | 1 (0.8) |
|
| 109 (39.8) |
| | 35 (32.1) |
| | 15 (13.8) |
| | 13 (11.9) |
| | 10 (9.2) |
| | 4 (3.7) |
| | 3 (2.8) |
| | 2 (1.8) |
| | 2 (1.8) |
| Other serotypesb | 25 (22.5) |
|
| 37 (13.5) |
| | 32 (86.5) |
| | 2 (5.4) |
| | 2 (5.4) |
| | 1 (2.7) |
|
| 10 (3.6) |
| | 8 (80) |
| | 1 (10) |
| | 1 (10) |
| Total | 274 (100) |
| Mixed infections (n = 5) | |
| EPEC/ | 1 |
| EPEC/ | 1 |
| EAEC/ | 1 |
| EPEC/ | 1 |
| EPEC/EAEC | 1 |
aThe serotype of STEC is O26:K60
bThe sum of the other serotypes excluding the top 8 serotypeslisted above
Fig. 1Isolated rate of enteropathogens per month in Beijing during 2010–2014
Antimicrobial resistance among Salmonella and Shigella isolates by serovars
| Antimicrobial | No. (%) resistance of S | No. (%) resistance of | |||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
| 1, 4, [5], 12:i:- (n = 13) |
| Overall (n = 109) |
|
|
| Overall (n = 37) | |
| AMP | 21 (60.0) | 12 (80.0) | 11 (84.6) | 1 (10.0) | 51 (46.8) | 31 (96.9) | 4 (100.0) | 0 (0.0) | 35 (94.6) |
| CHL | 3 (8.6) | 8 (53.3) | 4 (30.8) | 1 (10.0) | 18 (16.5) | 2 (6.3) | 4 (100.0) | 0 (0.0) | 6 (16.2) |
| CIP | 1 (2.9) | 6 (40.0) | 3 (23.1) | 0 (0.0) | 10 (9.2) | 0 (0.0) | 1 (25.0) | 0 (0.0) | 1 (2.7) |
| CRO | 7 (20.0) | 0 (0.0) | 2 (15.4) | 0 (0.0) | 10 (9.2) | 10 (31.3) | 1 (25.0) | 0 (0.0) | 11 (29.7) |
| GEN | 3 (8.6) | 7 (46.7) | 3 (23.1) | 1 (10.0) | 14 (12.8) | 30 (93.8) | 0 (0.0) | 0 (0.0) | 30 (81.1) |
| NAL | 34 (97.1) | 9 (60.0) | 5 (38.5) | 1 (10.0) | 61 (56.0) | 32 (100.0) | 4 (100.0) | 0 (0.0) | 36 (97.3) |
| STR | 15 (42.9) | 10 (66.7) | 12 (92.3) | 2 (20.0) | 48 (44.0) | 32 (100.0) | 4 (100.0) | 1 (100.0) | 37 (100.0) |
| SUL | 19 (54.3) | 12 (80.0) | 9 (69.2) | 2 (20.0) | 60 (55.0) | 32 (100.0) | 1 (25.0) | 1 (100.0) | 34 (91.9) |
| TET | 7 (20.0) | 10 (66.7) | 10 (76.9) | 1 (10.0) | 32 (29.4) | 12 (37.5) | 4 (100.0) | 1 (100.0) | 17 (45.9) |
| Multidrug-resistance (MDR) | |||||||||
| MDR3 | 22 (62.9) | 12 (80.0) | 11 (84.6) | 1 (10.0) | 54 (50.0) | 32 (100) | 4 (100.0) | 1 (100) | 37 (100) |
| MDR4 | 17 (48.6) | 12 (80.0) | 9 (69.2) | 1 (10.0) | 45 (41.3) | 31 (96.9) | 4 (100.0) | 0 (0.0) | 35 (94.6) |
| MDR5 | 7 (20.0) | 10 (66.7) | 5 (38.5) | 1 (10.0) | 25 (22.9) | 31 (96.9) | 4 (100.0) | 0 (0.0) | 35 (94.6) |
| MDR6 | 2 (5.7) | 7 (46.7) | 4 (30.8) | 1 (10.0) | 14 (12.8) | 18 (56.3) | 3 (75.0) | 0 (0.0) | 21 (56.8) |
For 109 Salmonella isolates, two dominant resistance patterns are AMP-STR-SUL-TET (n = 7, 6.4 %) and AMP-STR-SUL-NAL (n = 6, 5.5 %)
For 37 Shigella isolates, two dominant resistant patternsare AMP-GEN-NAL-STR-SUL (n = 12, 32.4 %) and AMP-GEN-NAL-STR-SUL-TET (n = 8, 21.6 %)
AMP ampicillin, CRO ceftriaxone, CIP ciprofloxacin, NAL nalidixic acid, TET tetracycline, GEN gentamicin, CHL chloramphenicol, SUL sulfisoxazole, STR streptomycin, MDR3 resistance to any three antibiotics, MDR4 resistance to any four antibiotics and so on